Astellas Pharma Inc (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2020 | 06-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Sales | 0 | 2,854,812 | 0 | 0 | 3,040,619 |
| Cost of Goods | N/A | 554,782 | N/A | N/A | 641,659 |
| Gross Profit | N/A | 2,300,030 | N/A | N/A | 2,398,960 |
| Operating Expenses | 0 | 1,735,232 | 0 | 0 | 1,698,128 |
| Operating Income | N/A | 565,580 | N/A | N/A | 701,483 |
| Interest Expense | 0 | 8,891 | 0 | 0 | 12,058 |
| Other Income | 0 | 3,525 | 0 | 0 | 6,980 |
| Pre-tax Income | 0 | 560,213 | 0 | 0 | 696,405 |
| Income Tax | N/A | 91,373 | N/A | N/A | 163,891 |
| Net Income Continuous | N/A | 468,841 | N/A | N/A | 532,514 |
| Net Income | $N/A | $468,841 | $N/A | $N/A | $532,514 |
| EPS Basic Total Ops | N/A | 0.25 | N/A | N/A | 0.28 |
| EPS Basic Continuous Ops | N/A | 0.25 | N/A | N/A | 0.28 |
| EPS Diluted Total Ops | N/A | 0.25 | N/A | N/A | 0.28 |
| EPS Diluted Continuous Ops | N/A | 0.25 | N/A | N/A | 0.28 |
| EPS Diluted Before Non-Recurring Items | 0.28 | N/A | 0.30 | N/A | N/A |
| EBITDA(a) | $N/A | $732,970 | $N/A | $N/A | $856,301 |